Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia

Leukemia, Published online: 26 February 2024; doi:10.1038/s41375-024-02162-5Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Source: Leukemia - Category: Hematology Authors: Source Type: research